The HPLC-ESI-MS measurements were carried out by the Northwest Metabolomics Research Center at the University of Washington using an Agilent 6545 Q-TOF mass spectrometer coupled with an Agilent 1290 Infinity LC pump, and an Agilent 6520 Q-TOF mass spectrometer coupled with Agilent 1260 Infinity LC system (Agilent Technologies). Samples consisted of phenol-chloroform extracts (prepared as described above) of either Buffer A alone or 50 μM purified CST in Buffer A. The HPLC separation was performed using a Waters XBridge BEH Amide column (15 cm x 2.1 mm, 2.5 μm). The mobile phase consisted of (A) H2O:acetonitrile (95:5, v/v), 5 mM ammonium acetate, and 0.1% acetic acid, and (B) H2O:acetonitrile (5:95, v/v), 5 mM ammonium acetate, and 0.1% acetic acid. Gradient operation was initiated at 94% of solvent B, and it decreased to 78% at t = 6.5 min, and to 39% at t = 12.0 min. Composition was maintained at 39% of solvent B until t = 18.5 min, followed by an increase to 94% at t = 19.0 min, and maintained at this condition until t = 35.0 min (total experimental time for each injection). The flow rate was 0.3 ml/min, the injection volume was 5 μl, followed by H2O:acetonitrile (5:95, v/v) needle wash for 10 s. The column was maintained at 35°C. The ESI conditions were as follows: electrospray ion source ESI Agilent Jet Stream Technology in positive ionization mode; voltage 3.8 kV; desolvation temperature 325°C; cone flow 20 l/h; desolvation gas flow 600 l/h; nebulizer pressure 45 psi, N2 was used as drying gas; MS scan rate of 5 spectra/s across the range m/z 60–1000, threshold count: 200; MS/MS acquisition rate 3 spectra/s, targeting precursor ion m/z 338.0701. Isolation width of 1.3 m/z, collision energies of 10 and 15 eV, m/z range of 50–500. Data were acquired using MassHunter Data Acquisition Workstation v. B.06.01.6157 software (Agilent Technologies, Palo Alto, CA). All solvents were LC-MS grade (Fisher Scientific). DI water (18.2 MΩ•cm at 25°C) was provided in-house by a Synergy Ultrapure Water System (EMD Millipore).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.